UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Journal of headache and pain, 2019-01, Vol.20 (1), p.6-6, Article 6

2019

Volltextzugriff (PDF)

Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta‐Analysis of Placebo‐Controlled Clinical Trials

Neuromodulation (Malden, Mass.), 2020-04, Vol.23 (3), p.291-300

2020

Volltextzugriff (PDF)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

Journal of headache and pain, 2022-06, Vol.23 (1), p.67-67, Article 67

2022

Volltextzugriff (PDF)

Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis

CNS drugs, 2018-11, Vol.32 (11), p.1069-1078

2018

Volltextzugriff (PDF)

Authors’ Reply to Tsivgoulis et al.: “Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis”

CNS drugs, 2019-03, Vol.33 (3), p.297-298

2019

Volltextzugriff (PDF)

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Journal of headache and pain, 2017-10, Vol.18 (1), p.108-20, Article 108

2017

Volltextzugriff (PDF)

TNFR2 on non‐haematopoietic cells is required for Foxp3+ Treg‐cell function and disease suppression in EAE

European journal of immunology, 2012-02, Vol.42 (2), p.403-412

2012

Volltextzugriff (PDF)

Validity and reliability of the Greek version of the neurogenic bladder symptom score (NBSS) questionnaire in a sample of Greek patients with multiple sclerosis

World journal of urology, 2021-07, Vol.39 (7), p.2697-2702

2021

Volltextzugriff (PDF)

Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population

Journal of molecular neuroscience, 2020-03, Vol.70 (3), p.467-474

2020

Volltextzugriff (PDF)

Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation

Journal of headache and pain, 2014-08, Vol.15 (1), p.47-47, Article 47

2014

Volltextzugriff (PDF)

Migraine in multiple sclerosis patients: potential links and treatment approach

Expert opinion on pharmacotherapy, 2023-11, Vol.24 (17), p.1845-1851

2023

Volltextzugriff (PDF)

Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms

Journal of molecular neuroscience, 2018-07, Vol.65 (3), p.367-376

2018

Volltextzugriff (PDF)

A meta-analytic approach to estimating nocebo effects in neuropathic pain trials

Journal of neurology, 2012-03, Vol.259 (3), p.436-447

2012

Volltextzugriff (PDF)

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Journal of headache and pain, 2019-05, Vol.20 (1), p.58-58, Article 58

2019

Volltextzugriff (PDF)

Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis

Multiple sclerosis and related disorders, 2024-05, Vol.85, p.105536-105536, Article 105536

2024

Volltextzugriff (PDF)

Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials

Journal of the neurological sciences, 2015-08, Vol.355 (1), p.94-100

2015

Volltextzugriff (PDF)

Nocebo effect in refractory partial epilepsy during pre-surgical monitoring: Systematic review and meta-analysis of placebo-controlled clinical trials

Seizure (London, England), 2017-02, Vol.45, p.95-99

2017

Volltextzugriff (PDF)

Correction to: Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis

CNS drugs, 2019-01, Vol.33 (1), p.93-97

2019

Volltextzugriff (PDF)

An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management

Expert review of neurotherapeutics, 2021-04, Vol.21 (4), p.475-490

2021

Volltextzugriff (PDF)

Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature

International review of neurobiology, 2018, Vol.139, p.443

2018

Volltextzugriff (PDF)

Nocebo in motor neuron disease: systematic review and meta-analysis of placebo-controlled clinical trials

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2017-10, Vol.18 (7-8), p.576-582

2017

Volltextzugriff (PDF)

Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders

Expert review of neurotherapeutics, 2021-08, Vol.21 (8), p.923-944

2021

Volltextzugriff (PDF)

Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials

Journal of the neurological sciences, 2018-05, Vol.388, p.79-83

2018

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece

Clinical drug investigation, 2019-10, Vol.39 (10), p.979-990

2019

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Safety, Tolerability, and Nocebo Phenomena During Transcranial Magnetic Stimulation: A Systematic Review and Meta‐Analysis of Placebo‐Controlled Clinical Trials

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis

Authors’ Reply to Tsivgoulis et al.: “Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis”

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

TNFR2 on non‐haematopoietic cells is required for Foxp3+ Treg‐cell function and disease suppression in EAE

Validity and reliability of the Greek version of the neurogenic bladder symptom score (NBSS) questionnaire in a sample of Greek patients with multiple sclerosis

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

Analysis of HCRTR2, GNB3, and ADH4 Gene Polymorphisms in a Southeastern European Caucasian Cluster Headache Population

Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation

Migraine in multiple sclerosis patients: potential links and treatment approach

Population-Based Analysis of Cluster Headache-Associated Genetic Polymorphisms

A meta-analytic approach to estimating nocebo effects in neuropathic pain trials

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis

Nocebo in Alzheimer's disease; meta-analysis of placebo-controlled clinical trials

Nocebo effect in refractory partial epilepsy during pre-surgical monitoring: Systematic review and meta-analysis of placebo-controlled clinical trials

Correction to: Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis

An updated brief overview on post-traumatic headache and a systematic review of the non-pharmacological interventions for its management

Nocebo Responses in Brain Diseases: A Systematic Review of the Current Literature

Nocebo in motor neuron disease: systematic review and meta-analysis of placebo-controlled clinical trials

Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders

Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials

Cost-Effectiveness Analysis of Erenumab Versus OnabotulinumtoxinA for Patients with Chronic Migraine Attacks in Greece

Suchergebnisse filtern